About Biozipcode, Inc.

What is the long-term strategy for growth and expansion in domestic and international markets?

January 21, 2024|Categories: About Biozipcode, Inc., Englsih|

Are clinical trials and research for diabetes cure methods and products ongoing, and what have been the results so far?

January 21, 2024|Categories: About Biozipcode, Inc., Englsih|

What are the main research and development areas, and how do they align with the company’s long-term goals?

January 21, 2024|Categories: About Biozipcode, Inc., Englsih|

Could you tell us about the current capital and sources of funding?

January 21, 2024|Categories: About Biozipcode, Inc., Englsih|

How is Biozipcode, Inc. addressing untreated diseases like diabetes?

January 21, 2024|Categories: About Biozipcode, Inc., Englsih|

About the establishment of Biozipcode, Inc.

January 21, 2024|Categories: About Biozipcode, Inc., Englsih|

KIYAN Group and Collaborating Research Institutions

KIYAN PHARMA Co., Ltd.

KIYAN MEDICAL Co., Ltd.

Biozipcode, Inc.

Shiga University of Medical Science, Dep. of Regenerative Medicine

Biozipcode, Inc.

We aim to completely cure diseases rather than just offering symptomatic treatments. We focus on developing a cure for diabetes and a technology that delivers medication to specific cells (cell targeting technology called “Biozipcode”).

Learn More About Us

Contact Us

Biozipcode, Inc.

TEL:
+81-50-5534-7865

E-MAIL:
info@biozipcode.com

ADDRESS:
Seta Tsukiwa-cho, Otsu City, Shiga Prefecture
Biomedical Innovation Center, Shiga University of Medical Science, 520-2121

Languages

© Copyright 2024 Biozipcode, Inc. All Rights Reserved.